Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.8K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acupuncture does not work and has no place in science-based medicine.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

PRC2 loss impairs small cell lung cancer tumorigenesis and enhances sensitivity to G9a/GLP inhibition.

Communications biology·2026
Same author

C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

Cancer research·2025
Same author

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

Molecular oncology·2025
Same author

Fasting boosts breast cancer therapy efficacy via glucocorticoid activation.

Nature·2025
Same author

European cancer research requires renewed urgency.

Nature cancer·2025

Related Experiment Video

Updated: May 4, 2026

CRISPR/Cas9-Mediated Highly Efficient Gene Targeting in Embryonic Stem Cells for Developing Gene-Manipulated Mouse Models
10:57

CRISPR/Cas9-Mediated Highly Efficient Gene Targeting in Embryonic Stem Cells for Developing Gene-Manipulated Mouse Models

Published on: August 24, 2022

4.6K

Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells.

Ivo J Huijbers1, Rahmen Bin Ali, Colin Pritchard

  • 1Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

EMBO Molecular Medicine
|January 10, 2014
PubMed
Summary

Genetically Engineered Mouse Models (GEMMs) accelerate cancer research by enabling rapid generation of tumor cohorts. This new method efficiently validates cancer genes and drug targets, identifying MycL1 as a key driver in Small Cell Lung Cancer.

More Related Videos

Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange
15:13

Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange

Published on: April 27, 2017

10.7K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Related Experiment Videos

Last Updated: May 4, 2026

CRISPR/Cas9-Mediated Highly Efficient Gene Targeting in Embryonic Stem Cells for Developing Gene-Manipulated Mouse Models
10:57

CRISPR/Cas9-Mediated Highly Efficient Gene Targeting in Embryonic Stem Cells for Developing Gene-Manipulated Mouse Models

Published on: August 24, 2022

4.6K
Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange
15:13

Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange

Published on: April 27, 2017

10.7K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Genetically Engineered Mouse Models (GEMMs) offer mechanistic insights into cancer development and drug target validation.
  • The complexity of GEMMs has historically limited their utility in preclinical studies.
  • A need exists for faster, more reliable methods to generate tumor cohorts for cancer gene assessment.

Purpose of the Study:

  • To develop a streamlined approach for generating tumor cohorts using GEMMs.
  • To overcome the limitations of complex GEMMs in preclinical cancer research.
  • To validate the utility of this approach for cancer gene discovery and drug target validation.

Main Methods:

  • Derivation of authentic Embryonic Stem Cells (ESCs) from established GEMMs.
  • Introduction of transgenes into GEMM-ESCs via Flp recombinase-mediated integration.
  • Direct utilization of chimeric animals derived from GEMM-ESCs to form tumor cohorts.

Main Results:

  • A novel, efficient system for the rapid generation of tumor cohorts from GEMMs was established.
  • Stringent quality controls ensure the reliability and effectiveness of the GEMM-ESC approach.
  • MycL1 was identified as a key driver gene in Small Cell Lung Cancer, demonstrating proof-of-principle.

Conclusions:

  • The GEMM-ESC approach significantly accelerates cancer gene assessment and drug target validation.
  • This method provides a reliable platform for preclinical cancer research.
  • MycL1 represents a potential therapeutic target in Small Cell Lung Cancer.